← Back to Clinical Trials
Recruiting NCT05450510

NCT05450510 Slow and Accelerated Rehabilitation Protocols

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05450510
Status Recruiting
Phase
Sponsor Hacettepe University
Condition Rotator Cuff Injuries
Study Type INTERVENTIONAL
Enrollment 38 participants
Start Date 2022-04-27
Primary Completion 2025-11-27

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Accelerated (ACCEL) protocol groupSlow (SLOW) protocol group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 38 participants in total. It began in 2022-04-27 with a primary completion date of 2025-11-27.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Latissimus dorsi transfer is an established treatment option with favorable results in massive, irreparable rotator cuff tears, however, it is controversial if earlier motion is detrimental or beneficial to the postoperative goal of reduced pain and improved clinical outcomes. Therefore, the aim of this study is to compare the effects of slow and accelerated rehabilitation protocols after latissimus dorsi transfer in massive, irreparable rotator cuff tears.

Eligibility Criteria

Inclusion Criteria: * being in the age range of 18-65 years * being diagnosed with massive, irreparable rotator cuff tears based on magnetic resonance imaging and clinical continuity tests * symptoms are unresponsive to conservative care including steroid injections and physiotherapy for at least 6 months * having a good command of the Turkish language * scoring above 24 in the Mini Mental State Test * ≥80% compliance in completing the post-ARCR Phase 1 trainings * volunteering to participate in the study Exclusion Criteria: * diabetes mellitus * neurological problems * cervical disc herniation * visual, verbal, and/or cognitive defects (aphasia, unilateral neglect, etc.) * systemic inflammatory problems * hypermobility, trauma, and/or inflammation that could be a contraindication for mobilization * former shoulder fractures on the affected side * advanced glenohumeral arthritis (Hamada grade 3), * deltoid muscle dysfunction, * irreparable subscapularis tears, * active infection, * shoulder stiffness, * a history of previous shoulder surgery

Contact & Investigator

Central Contact

Caner KARARTI, Asst. Prof.

✉ fzt.caner.92@gmail.com

📞 +903862805362

Frequently Asked Questions

Who can join the NCT05450510 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Rotator Cuff Injuries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05450510 currently recruiting?

Yes, NCT05450510 is actively recruiting participants. Contact the research team at fzt.caner.92@gmail.com for enrollment information.

Where is the NCT05450510 trial being conducted?

This trial is being conducted at Kırşehir, Turkey (Türkiye).

Who is sponsoring the NCT05450510 clinical trial?

NCT05450510 is sponsored by Hacettepe University. The trial plans to enroll 38 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology